178 related articles for article (PubMed ID: 35151542)
1. Antiseptic barrier caps in central line-associated bloodstream infections: A systematic review and meta-analysis.
Tejada S; Leal-Dos-Santos M; Peña-López Y; Blot S; Alp E; Rello J
Eur J Intern Med; 2022 May; 99():70-81. PubMed ID: 35151542
[TBL] [Abstract][Full Text] [Related]
2. Effect of the use of an antiseptic barrier cap on the rates of central line-associated bloodstream infections in neonatal and pediatric intensive care.
Helder OK; van Rosmalen J; van Dalen A; Schafthuizen L; Vos MC; Flint RB; Wildschut E; Kornelisse RF; Ista E
Am J Infect Control; 2020 Oct; 48(10):1171-1178. PubMed ID: 31948717
[TBL] [Abstract][Full Text] [Related]
3. Antiseptic barrier cap effective in reducing central line-associated bloodstream infections: A systematic review and meta-analysis.
Voor In 't Holt AF; Helder OK; Vos MC; Schafthuizen L; Sülz S; van den Hoogen A; Ista E
Int J Nurs Stud; 2017 Apr; 69():34-40. PubMed ID: 28130997
[TBL] [Abstract][Full Text] [Related]
4. Antiseptic barrier caps to prevent central line-associated bloodstream infections: A systematic review and meta-analysis.
Gillis VELM; van Es MJ; Wouters Y; Wanten GJA
Am J Infect Control; 2023 Jul; 51(7):827-835. PubMed ID: 36116679
[TBL] [Abstract][Full Text] [Related]
5. A quality improvement study on the reduction of central venous catheter-associated bloodstream infections by use of self-disinfecting venous access caps (STERILE).
Cruz-Aguilar R; Carney J; Mondaini V; Vehreschild MJGT; Griskaitis M; Salmanton-García J; Böll B; Kochanek M; Seifert H; Biehl LM; Farowski F
Am J Infect Control; 2021 May; 49(5):586-592. PubMed ID: 32966854
[TBL] [Abstract][Full Text] [Related]
6. Are antimicrobial peripherally inserted central catheters associated with reduction in central line-associated bloodstream infection? A systematic review and meta-analysis.
Kramer RD; Rogers MA; Conte M; Mann J; Saint S; Chopra V
Am J Infect Control; 2017 Feb; 45(2):108-114. PubMed ID: 28341283
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of chlorhexidine patches on central line-associated bloodstream infections in children.
Jitrungruengnij N; Anugulruengkitt S; Rattananupong T; Prinyawat M; Jantarabenjakul W; Wacharachaisurapol N; Chatsuwan T; Janewongwirot P; Suchartlikitwong P; Tawan M; Kanchanabutr P; Pancharoen C; Puthanakit T
Pediatr Int; 2020 Jul; 62(7):789-796. PubMed ID: 32065485
[TBL] [Abstract][Full Text] [Related]
8. Catheter impregnation, coating or bonding for reducing central venous catheter-related infections in adults.
Lai NM; Chaiyakunapruk N; Lai NA; O'Riordan E; Pau WS; Saint S
Cochrane Database Syst Rev; 2013 Jun; (6):CD007878. PubMed ID: 23740696
[TBL] [Abstract][Full Text] [Related]
9. Effect of skin antiseptic solutions on the incidence of catheter-related bloodstream infection: a systematic review and network meta-analysis.
Masuyama T; Yasuda H; Sanui M; Lefor AK
J Hosp Infect; 2021 Apr; 110():156-164. PubMed ID: 33529623
[TBL] [Abstract][Full Text] [Related]
10. Reduction in Central Line-Associated Bloodstream Infections Correlated With the Introduction of a Novel Silver-Plated Dressing for Central Venous Catheters and Maintained for 6 Years.
Karlnoski R; Abboud EC; Thompson P; Oxner AZ; Sinnott JT; Marcet JE
J Intensive Care Med; 2019 Jul; 34(7):544-549. PubMed ID: 29216782
[TBL] [Abstract][Full Text] [Related]
11. Central line-associated bloodstream infection prevention: "scrub the hub" or antiseptic barrier caps?
Ture Z; Blot S; Alp E
Intensive Crit Care Nurs; 2023 Aug; 77():103442. PubMed ID: 37120363
[No Abstract] [Full Text] [Related]
12. The use of 3.15% chlorhexidine gluconate/70% alcohol hub disinfection to prevent central line-associated bloodstream infections in dialysis patients.
Marty Cooney R; Manickam N; Becherer P; Harmon LS; Gregg L; Farkas Z; Shea LM; Parekh P; Murphy J; Shade W
Br J Nurs; 2020 Jan; 29(2):S24-S26. PubMed ID: 31972108
[TBL] [Abstract][Full Text] [Related]
13. The risk of bloodstream infection associated with peripherally inserted central catheters compared with central venous catheters in adults: a systematic review and meta-analysis.
Chopra V; O'Horo JC; Rogers MA; Maki DG; Safdar N
Infect Control Hosp Epidemiol; 2013 Sep; 34(9):908-18. PubMed ID: 23917904
[TBL] [Abstract][Full Text] [Related]
14. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter. A randomized, controlled trial.
Maki DG; Stolz SM; Wheeler S; Mermel LA
Ann Intern Med; 1997 Aug; 127(4):257-66. PubMed ID: 9265424
[TBL] [Abstract][Full Text] [Related]
15. Prevention of hospital-acquired bloodstream infections through chlorhexidine gluconate-impregnated washcloth bathing in intensive care units: a systematic review and meta-analysis of randomised crossover trials.
Afonso E; Blot K; Blot S
Euro Surveill; 2016 Nov; 21(46):. PubMed ID: 27918269
[TBL] [Abstract][Full Text] [Related]
16. Alcohol-impregnated caps and ambulatory central-line-associated bloodstream infections (CLABSIs): A randomized clinical trial.
Milstone AM; Rosenberg C; Yenokyan G; Koontz DW; Miller MR;
Infect Control Hosp Epidemiol; 2021 Apr; 42(4):431-439. PubMed ID: 33040755
[TBL] [Abstract][Full Text] [Related]
17. Types of urethral catheters for management of short-term voiding problems in hospitalized adults: a short version Cochrane review.
Schumm K; Lam TB
Neurourol Urodyn; 2008; 27(8):738-46. PubMed ID: 18951451
[TBL] [Abstract][Full Text] [Related]
18. Use of alcohol containing caps for preventing bloodstream infections: A randomized controlled trial.
Taşdelen Öğülmen D; Ateş S
J Vasc Access; 2021 Nov; 22(6):920-925. PubMed ID: 32854563
[TBL] [Abstract][Full Text] [Related]
19. Comparative Efficacy of Antimicrobial Central Venous Catheters in Reducing Catheter-Related Bloodstream Infections in Adults: Abridged Cochrane Systematic Review and Network Meta-Analysis.
Chong HY; Lai NM; Apisarnthanarak A; Chaiyakunapruk N
Clin Infect Dis; 2017 May; 64(suppl_2):S131-S140. PubMed ID: 28475779
[TBL] [Abstract][Full Text] [Related]
20. Dialysis Catheter-Related Bloodstream Infections: A Cluster-Randomized Trial of the ClearGuard HD Antimicrobial Barrier Cap.
Hymes JL; Mooney A; Van Zandt C; Lynch L; Ziebol R; Killion D
Am J Kidney Dis; 2017 Feb; 69(2):220-227. PubMed ID: 27839894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
